Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Alibaba Group Holding Ltd (BABA) Penetrates into Rapidly Growing Online Drug Market

Alibaba Group Holding Ltd (NYSE:BABA) just like other pharmaceutical companies in China is closely eyeing the online health and drug distribution business as everything moves to the cloud. The e-commerce giant plans to work with pharmacy chains across the country that will be used to handle the orders for drugs it receives online.

Alibaba, is BABA a good stock to buy, Henry Blodget, China, government risk,

Shanghai Pharmaceutical company is looking to provide 020 sales of prescription drugs as well as health management services for patient’s .The company’s head of strategic operations, Liu Dawei, affirms that the new venture plans to build on prescription drugs that are not covered by China’s national medical insurance scheme within the next six months. The company also plans to expand its catalogue of drugs to cover areas of Cancer, antibiotics, as well as liver disease.

Alibaba Group Holding Ltd (NYSE:BABA) is also pursuing the business, having already set up an Alibaba health information Technology (ALI Health). The portal essentially allows customers to look for prescribed drugs and compare their prices.

Ali Health specializes in offering a wide array of information management solutions for hospitals operating online drug stores. Alibaba has also signed a strategic partnership with Guangzhou Women and Children’s Medical Center that will see the hospital adopting the company’s hospital information system.

Alibaba Group Holding Ltd (NYSE:BABA) has already invited the 180,000 clinics in the country to join its online cloud platform as the company moves to make its presence felt in the online drug market. The e-commerce sensation has also established a partnership with three major pharmacy’s in the northern city of Shijiazhuang in addition to eight more chains in its home base of Hangzhou.

The entry of Alibaba Group Holding Ltd (NYSE:BABA) into the space is expected to have a disruption effect especially to smaller drug makers operating online sales. The size of Alibaba justifies the fact that the company will be able to store many drugs many of which may be sold on a discount knocking off smaller drug makers, upon receiving a license for the sale of prescription drugs.

Despite the fact that China has not yet lifted the restriction on the sale of prescription drugs online, many internet, and pharmaceutical companies continue to adopt the online medical service and drug distribution business.

I jsut made 84% in 4 daysI Just Made 84% in 4 Days By Blindly Following This Hedge Fund

I just made 84% in 4 days by blindly imitating a hedge fund’s stock pick. I will tell you how I pulled such a huge return in such a short time but let me first explain in this FREE REPORT why following hedge funds’ stock picks is one of the smartest things you can do as an investor. We launched our quarterly newsletter 2.5 years ago and not one subscriber has, since, said “I lost money by EXACTLY following your stock picks”. The reason is simple. You can beat index funds by creating a DREAM TEAM of hedge fund managers and investing in only their best ideas. I just made 84% in 4 days by blindly imitating one of these best ideas. CLICK HERE NOW for all the details.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!